Concentra Group Holdings Parent, Inc. (CON)
NYSE:CON
Want to see CON full AI Analyst Report?
CON Stock Chart & Stats
$22.86
$0.10(0.50%)
At close: 4:00 PM EST
$22.86
$0.10(0.50%)
Day’s Range― - ―
52-Week Range$18.55 - $28.94
Previous CloseN/A
Volume132.54K
Average Volume (3M)1.01M
Market Cap
$3.86B
Enterprise Value$5.69B
Total Cash (Recent Filing)$61.70M
Total Debt (Recent Filing)$2.12B
Price to Earnings (P/E)21.7
Beta0.52
Next Earnings
Jul 30, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend Yield1.27%
Share Statistics
EPS (TTM)1.39
Shares Outstanding127,961,780
10 Day Avg. Volume992,419
30 Day Avg. Volume1,007,289
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap1.47
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit9.18
Enterprise Value/Ebitda13.22
Forecast
1Y Price Target
$32.00Price Target Upside39.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.52
Revenue Forecast (FY)$2.33B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent and improving free cash flow provides durable funding for capex, dividends, buybacks and deleveraging. FCF roughly matching net income signals high earnings quality, enabling strategic investments and reducing reliance on external financing over the medium term.
Sustained Revenue And Visit GrowthRobust top-line and visit expansion point to underlying demand for occupational and employer health services. Broad-based volume growth supports unit economics and provides a recurring revenue foundation that tends to persist as companies maintain workforce health programs.
Successful M&A And On-site Clinic ScalingProven ability to integrate tuck-ins and rapidly scale on-site clinics expands addressable market and creates cross-sell synergies. Successful integrations improve rollout cadence and lower future acquisition execution risk, supporting durable revenue diversification away from center-based care.
Bears Say
Elevated And Volatile LeverageHistoric surge in leverage materially increases financial risk and sensitivity to cash flow swings. Even with TTM improvement, the capital structure restricts flexibility for large investments, raises refinancing risk in downturns, and amplifies earnings volatility from operational setbacks.
Step-down In Operating ProfitabilityA notable decline in operating margins signals cost or mix pressures that can compress cash generation and returns. If persistent, margin erosion reduces ability to fund growth organically and slows deleveraging, making earnings more sensitive to volume fluctuations.
Employer Services Growth Lagging; Mix RiskSlower employer services expansion and reliance on workers' comp lift exposure to hiring cycles and state rate timing. A skewed revenue mix raises demand cyclicality and limits diversification, making revenue and margin performance more vulnerable to macro and regulatory shifts.
Concentra Group Holdings Parent, Inc. News
CON FAQ
What was Concentra Group Holdings Parent, Inc.’s price range in the past 12 months?
Concentra Group Holdings Parent, Inc. lowest stock price was $18.55 and its highest was $28.94 in the past 12 months.
What is Concentra Group Holdings Parent, Inc.’s market cap?
Concentra Group Holdings Parent, Inc.’s market cap is $3.86B.
When is Concentra Group Holdings Parent, Inc.’s upcoming earnings report date?
Concentra Group Holdings Parent, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 32 days.
How were Concentra Group Holdings Parent, Inc.’s earnings last quarter?
Concentra Group Holdings Parent, Inc. released its earnings results on May 07, 2026. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.338 by $0.062.
Is Concentra Group Holdings Parent, Inc. overvalued?
According to Wall Street analysts Concentra Group Holdings Parent, Inc.’s price is currently Undervalued.
Does Concentra Group Holdings Parent, Inc. pay dividends?
Concentra Group Holdings Parent, Inc. pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 1.27%. See more information on Concentra Group Holdings Parent, Inc. dividends here
What is Concentra Group Holdings Parent, Inc.’s EPS estimate?
Concentra Group Holdings Parent, Inc.’s EPS estimate is 0.43.
How many shares outstanding does Concentra Group Holdings Parent, Inc. have?
Concentra Group Holdings Parent, Inc. has 127,961,780 shares outstanding.
What happened to Concentra Group Holdings Parent, Inc.’s price movement after its last earnings report?
Concentra Group Holdings Parent, Inc. reported an EPS of $0.4 in its last earnings report, beating expectations of $0.338. Following the earnings report the stock price went up 2.373%.
Which hedge fund is a major shareholder of Concentra Group Holdings Parent, Inc.?
Currently, no hedge funds are holding shares in CON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concentra Group Holdings Parent, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.00 (39.98% Upside)
$32.00 (39.98% Upside)
Blogger Sentiment
Bullish
CON Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 153.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 10.3%
Last 30 Days ▲ 10.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.11%
12-Months-Change
Fundamentals
Return on Equity
46.05%
Trailing 12-Months
Asset Growth
5.88%
Trailing 12-Months
Company Description
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.
CON Company Deck
CON Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive picture: revenue, visit volumes, adjusted EBITDA, margins, and free cash flow all improved materially year‑over‑year, and management raised 2026 guidance. Strategic M&A integrations (Nova and Pivot) are ahead of plan and on‑site clinic growth is accelerating. Offsetting items include modestly higher adjusted G&A tied to separation and investments, elevated absolute debt and leverage that management is working to reduce, and slower employer services growth and state rate timing/mix headwinds. Overall, the positive operational and financial momentum and raised guidance outweigh the manageable challenges.View all CON earnings summariesCON Stock 12 Month Forecast
Average Price Target
$32.00
▲(39.98% Upside)
Technical Analysis
Labcorp Holdings
―
Envista Holdings
―
Safe Pro Group, Inc.
―
Flowco Holdings Inc Class A
―
Beta Bionics, Inc.
―
Ownership Overview
8.03% Insiders
34.35% Mutual Funds
14.79% Other Institutional Investors
18.77% Public Companies and
Individual Investors